evenfolio

Financial Services · NSE: RELIGARE

Religare Enterprises

Q2 FY27 earnings highlights, from the results presentation

Price as of 16 Nov 2026
225.46−3.62%
M.Cap
₹7,693Cr
P/E
-196.0×
1Y return
−13.28%
From 52W high
−19.5%

Highlights are read by AI from the company's filing and can contain mistakes. Check the source page linked to each line.

Share price

Results Q2 FY27, as filed · consolidated · ₹ Cr

Q2 FY27Q2 FY26YoYQ1 FY27QoQ
Revenue2,3812,064+15.3%2,353+1.2%
PBTProfit before tax-12857-322.4%-77—
Net profit-5039-228.7%-26—
EPS (₹)-1.451.15-226.1%-0.78—

From the company's own results filing on NSE. Net profit is the owners' share. Growth and the dotted lines are worked out from the filed figures.

In short

  1. 01Consolidated net loss of Rs 144.67 crore in H1 FY27, against a profit of Rs 54.05 crore in H1 FY26
  2. 02Insurance segment posted a pre-tax loss of Rs 158.19 crore in Q2 FY27
  3. 03Religare Finvest restarted lending on 6 Nov 2026 with a debt-free balance sheet
  4. 04Care Health premium grew about 35% year on year; overall retail grew 44%
  5. 05Care Health raised Rs 450 crore of Tier II capital; total outstanding debt Rs 550 crore
  6. 06REL made a Rs 250 crore capital commitment to the housing finance arm
  7. 07Religare Broking raised Rs 100 crore by rights issue; CRISIL upgraded its long-term rating

Segments

Insurance: Insurance segment pre-tax loss of Rs 158.19 Cr in Q2 FY27; financial services profit Rs 37.29 Cr

Slides · p. 9
“Segment Performance (158.19) 37.29 (6.89) (127.79)”

Religare Broking: Religare Broking H1 FY27 total income up 7% to Rs 197 Cr

Slides · p. 12
“+7% YoY Growth in H1 FY27 Total Income to Rs. 197 Cr.,”

Religare Broking: Religare Broking H1 FY27 PBT up 29% to Rs 13 Cr

Slides · p. 12
“+29% YoY Growth in H1 FY27 PBT to ₹ 13 Cr.”

Religare Broking: Client debit book of Religare Broking grew 51% year on year

Slides · p. 12
“+51% YoY Growth in Client Debit Book”

Religare Broking: Religare Broking Q2 FY27 PAT of Rs 2.2 Cr vs Rs 2.6 Cr a year ago

Slides · p. 15
“Profit After Tax 2.2 2.6 7.5 9.7 7.5”

Demand

Religare Broking: Broking cash volumes normalised with industry; derivatives moderated sequentially

Slides · p. 14
“Cash Volumes Normalize in Tandem with Industry-Wide Exchange Activity Sequential Moderation in Derivatives While YoY Growth Sustains”

Religare Broking: Broking assets under custody rebounded after Q4 dip; client participation stabilising

Slides · p. 14
“Assets Under Custody Rebound Strongly Following Q4 Dip Client Participation Stabilizes with Gradual Rebound in FY27”

Religare Housing: Affordable housing market in Tier-2 and beyond cited at about 20% CAGR

Slides · p. 24
“~20% CAGR in Tier-2 and beyond”

Care Health Insurance: Care Health retail growth in cities beyond the top 11 outpacing the top 11

Slides · p. 28
“retail business growth in cities beyond the Top 11”

Margins and costs

Religare Housing: Housing finance depreciation rose to Rs 2.59 Cr in Q2 FY27 from Rs 0.32 Cr

Slides · p. 26
“Depreciation (2.59) (0.32) (0.34) (2.93) (0.66)”

Care Health Insurance: Care Health combined insurance service ratio 100.5% vs 101.2% a year ago

Slides · p. 35
“Combined Insurance Service Ratio (CISR = CR + ER) 100.5% 101.2%”

Care Health Insurance: Care Health combined ratio 111.1% in Q2 FY27 vs 107.7% a year ago

Slides · p. 36
“Combined Ratio 111.1% 107.7% 110.7% 110.9% 108.6%”

Care Health Insurance: Care Health claims ratio 72.8% in Q2 FY27 vs 70.4% a year ago

Slides · p. 36
“Claims Ratio 72.8% 70.4% 77.2% 75.0% 73.4%”

Consolidated fee and commission expenses Rs 468.72 Cr in Q2 FY27 vs Rs 367.17 Cr

Slides · p. 8
“Fee and Commission Expenses 468.72 367.17 384.86 853.58 661.41”

Debt and working capital

Religare Broking: Religare Broking long-term rating upgraded to CRISIL BBB+/Stable from BBB/Stable

Slides · p. 12
“facilities: Long-Term: CRISIL BBB+/Stable (from BBB/Stable);”

Religare Broking: Religare Broking short-term rating upgraded to CRISIL A2+ from A3+

Slides · p. 12
“Short-Term: CRISIL A2+ (from A3+)”

Religare Finvest: Religare Finvest tangible net worth of about Rs 963 Cr

Slides · p. 19
“position with a tangible net worth of ~Rs.963 Cr,”

Religare Finvest: Religare Finvest cash and liquid investments of about Rs 660 crore

Slides · p. 19
“of ~Rs.660 crore ensure adequate liquidity and”

Religare Finvest: Religare Finvest has a debt-free balance sheet

Slides · p. 19
“Debt free balance sheet, paving the way”

Fund raising

Religare Broking: Religare Broking raised Rs 100 crore through a rights issue from its parent

Slides · p. 12
“Raised ₹100 crore through a Rights Issue from its Parent”

Religare Broking: Rights issue done in August 2026, out of Rs 200 Cr earmarked by REL

Slides · p. 12
“Company in August 2026 out of Rs. 200 Cr. earmarked by”

Religare Housing: REL made Rs 250 Cr strategic capital commitment to housing finance arm

Slides · p. 23
“Rs 250 Cr strategic capital commitment by”

Religare Housing: Capital infusion into housing finance arm planned in FY27

Slides · p. 24
“Planned capital infusion in FY27 to”

Care Health Insurance: Care Health raised Rs 450 Cr through Tier II capital

Slides · p. 28
“Raised Rs. 450 Cr through Tier II capital (raised”

Acquisitions and new business

Religare Finvest: Religare Finvest restarted lending on 6 Nov 2026

Slides · p. 18
“Lending restarted on 6 Nov 2026”

Religare Finvest: Religare Finvest to focus on secured, collateral-backed retail lending

Slides · p. 18
“Secured-first retail lending: collateral-backed, granular, resilient”

Management

Religare Finvest: Religare Finvest says it has set up a strengthened leadership team

Slides · p. 19
“Leadership Readiness: Established a strengthened”

One-offs

Religare Finvest: Religare Finvest wrote off stage III exposure to reach zero NPA

Slides · p. 19
“Zero NPA Status : Written off the stage III exposure to”

Religare Finvest: Religare Finvest net provisions line (net of recovery) Rs 26.4 Cr in Q2 FY27

Slides · p. 21
“Net Provisions 26.4 28.0 20.2 46.6 42.3”

Risks

Religare Broking: Broking profitability declined due to tough business environment; Rs 100 Cr capital infused

Slides · p. 13
“Tough Business Environment led to decline in profitability Balance Sheet Strengthened by capital infusion of Rs.100 Cr”

Other

Consolidated net loss of Rs 144.67 Cr in H1 FY27 vs profit of Rs 54.05 Cr in H1 FY26

Slides · p. 8
“Net Profit / (Loss) for the period (97.69) 45.93 (46.98) (144.67) 54.05”

Consolidated pre-tax loss of Rs 127.79 Cr in Q2 FY27 vs profit of Rs 57.45 Cr a year ago

Slides · p. 8
“Profit / (Loss) Before Tax (127.79) 57.45 (76.73) (204.51) 63.18”

REL standalone: Standalone REL net loss of Rs 23.05 Cr in H1 FY27

Slides · p. 10
“Net Profit/ (Loss) after tax (13.45) (3.98) (9.62) (23.05) (10.12)”

Care Health Insurance: Care Health investment book expanded to Rs 12,897 Cr

Slides · p. 28
“Investment Book expanded to Rs. 12,897 Cr ,”

Care Health Insurance: Care Health investment book gross debt yield of 7.3%

Slides · p. 28
“providing a gross debt yield of 7.3%”

Sources

Management's own statements, quoted from its NSE filings. This page was read by AI and can contain mistakes: check the source pages before relying on any figure. No forecast or opinion of ours. Not investment advice.

Search

Search funds, ETFs, stocks, pages and tools